“Varian and Tata Trusts Sign Framework Agreement for Advanced Cancer Care Solutions to Address Growing Need in India” reported Varian about the “three-year agreement is focused on world-class cancer care delivery through the installation of radiation therapy treatment systems across India where Varian has been selected as the preferred supplier by Tata Trusts”.

Cyril Amarchand Mangaldas advised Tata Trusts, acting through Sir Ratan Tata Trusts led by a team of managing partner Cyril Shroff, and general corporate partner Ramgovind Kuruppath and senior associate Shejal Verma.

2019-03-07

Deal value: Not disclosed

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.